Advertisement
Review article| Volume 42, P76-86, May 2020

Download started.

Ok

Reducing post-caesarean delivery surgical site infections: a narrative review

  • S.E. Douville
    Affiliations
    Faculty of Medicine, The University of Queensland, Herston, Queensland, Australia
    Search for articles by this author
  • L.K. Callaway
    Affiliations
    Faculty of Medicine, The University of Queensland, Herston, Queensland, Australia

    Department of Obstetrics and Gynaecology/Obstetric Medicine, The Royal Brisbane and Women’s Hospital, Herston, Queensland, Australia
    Search for articles by this author
  • A. Amoako
    Affiliations
    Faculty of Medicine, The University of Queensland, Herston, Queensland, Australia

    Department of Obstetrics and Gynaecology/Obstetric Medicine, The Royal Brisbane and Women’s Hospital, Herston, Queensland, Australia
    Search for articles by this author
  • J.A. Roberts
    Affiliations
    Faculty of Medicine, The University of Queensland, Herston, Queensland, Australia

    University of Queensland Centre for Clinical Research, The University of Queensland, Herston, Queensland, Australia

    Centre for Translational Anti-infective Pharmacodynamics, School of Pharmacy, The University of Queensland, Herston, Queensland, Australia

    Division of Anaesthesiology Critical Care Emergency and Pain Medicine, Nîmes University Hospital, University of Montpellier, Nîmes, France

    Department of Pharmacy and Intensive Care Medicine, The Royal Brisbane and Women’s Hospital, Herston, Qld, Australia
    Search for articles by this author
  • V.A. Eley
    Correspondence
    Correspondence to: V.A. Eley, Department of Anaesthesia and Perioperative Medicine, The Royal Brisbane and Women’s Hospital, Butterfield St Herston, 2006 Queensland, Australia.
    Affiliations
    Faculty of Medicine, The University of Queensland, Herston, Queensland, Australia

    Department of Anaesthesia and Perioperative Medicine, The Royal Brisbane and Women’s Hospital, Herston, Queensland, Australia
    Search for articles by this author
Published:September 05, 2019DOI:https://doi.org/10.1016/j.ijoa.2019.08.007

      Highlights

      • Reported post-caesarean surgical site infection (SSI) rates vary from 1% to 10%.
      • International variation is seen in recommended prophylactic antibiotic regimens.
      • Surgical technique for wound closure influences SSI rate.

      Abstract

      Surgical site infection complicates 1–10% of caesarean deliveries. With the rate of caesarean delivery increasing, it is important to identify effective measures of preventing surgical site infection and to consider their impact on maternal and neonatal outcomes. Compelling evidence supports the use of prophylactic antibiotics, prior to skin incision, to reduce surgical site infection. However, there remain international variations in terms of the recommended agent, dose and body weight-adjusted dosing. Advances in wound dressings are an evolving area of interest and surgical technique can influence outcomes. This narrative review explores pharmacological and non-pharmacological methods of preventing surgical site infection following caesarean delivery.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to International Journal of Obstetric Anesthesia
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Conroy K.
        • Koenig A.F.
        • Yu Y.-H.
        • Courtney A.
        • Lee H.J.
        • Norwitz E.R.
        Infectious morbidity after cesarean delivery: 10 strategies to reduce risk.
        Rev Obstet Gynecol. 2012; 5: 69-77
        • Yokoe D.S.
        • Christiansen C.L.
        • Johnson R.
        • et al.
        Epidemiology of and surveillance for postpartum infections.
        Emerg Infect Dis. 2001; 7: 837
      1. CDC Procedure-Associated Module SSI. United States: Centers for Disease Control and Prevention, 2019. Available at: https://www.cdc.gov/nhsn/faqs/faq-ssi-proc-codes.html. Accessed July 7, 2019.

        • Burrows L.J.
        • Meyn L.A.
        • Weber A.M.
        Maternal morbidity associated with vaginal versus cesarean delivery.
        Obstet Gynecol. 2004; 103: 907-912
        • Declercq J.E.
        • Barger R.M.
        • Cabral J.H.
        • et al.
        Maternal outcomes associated with planned primary cesarean births compared with planned vaginal births.
        Obstet Gynecol. 2007; 109: 669-677
        • Brown J.
        • Thompson M.
        • Sinnya S.
        • et al.
        Pre-incision antibiotic prophylaxis reduces the incidence of post-caesarean surgical site infection.
        J Hosp Infect. 2013; 83: 68-70
        • El-Achi V.
        • Wan K.M.
        • Brown J.
        • Marshall D.
        • McGee T.
        Readmissions for surgical site infections following caesarean section.
        Aust NZ J Obstet Gynaecol. 2018; 58: 582-585
        • McKibben R.A.
        • Pitts S.I.
        • Suarez-Cuervo C.
        • Perl T.M.
        • Bass E.B.
        Practices to reduce surgical site infections among women undergoing cesarean section: a review.
        Infect Control Hosp Epidemiol. 2015; 36: 915-921
        • Sarah H.Y.
        • Perkins K.M.
        • Kazakova S.V.
        • et al.
        Surgical site infection risk following cesarean deliveries covered by medicaid or private insurance.
        Infect Control Hosp Epidemiol. 2019; 40: 639-648
        • Moulton L.J.
        • Munoz J.L.
        • Lachiewicz M.
        • Liu X.
        • Goje O.
        Surgical site infection after cesarean delivery: incidence and risk factors at a US academic institution.
        J Matern Fetal Neonatal Med. 2018; 31: 1873-1880
        • Wilson J.
        • Wloch C.
        • Saei A.
        • et al.
        Inter-hospital comparison of rates of surgical site infection following caesarean section delivery: evaluation of a multicentre surveillance study.
        J Hosp Infect. 2013; 84: 44-51
        • Edwards J.R.
        • Peterson K.D.
        • Mu Y.
        • et al.
        National Healthcare Safety Network (NHSN) report: data summary for 2006 through 2008, issued December 2009.
        Am J Infect Control. 2009; 37: 783-805
        • Pierson R.C.
        • Scott N.P.
        • Briscoe K.E.
        • Haas D.M.
        A review of post-caesarean infectious morbidity: how to prevent and treat.
        J Obstet Gynaecol. 2018; 38: 591-597
        • Wloch C.
        • Wilson J.
        • Lamagni T.
        • Harrington P.
        • Charlett A.
        • Sheridan E.
        Risk factors for surgical site infection following caesarean section in England: results from a multicentre cohort study.
        BJOG. 2012; 119: 1324-1333
        • Lakhan D.
        • Doherty J.
        • Jones M.
        • Clements A.
        A systematic review of maternal intrinsic risk factors associated with surgical site infection following Caesarean sections.
        Healthcare Infection. 2010; 15: 35-41
        • Temming L.A.
        • Raghuraman N.
        • Carter E.B.
        • et al.
        Impact of evidence-based interventions on wound complications after cesarean delivery.
        Am J Obstet Gynecol. 2017; 217 (4491.e1–449.e9)
      2. eTG complete. Melbourne, Australia: Therapeutic Guidelines Ltd, 2019. Antibiotics: Surgical prophylaxis. Available at: https://tgldcdp.tg.org.au/viewTopic?topicfile=surgical-prophylaxis#toc_d1e1413. Accessed June 1, 2019.

        • Hermanides J.
        • Lemkes B.A.
        • Prins J.M.
        • Hollmann M.W.
        • Terreehorst I.
        Presumed β-lactam allergy and cross-reactivity in the operating theater: a practical approach.
        Anesthesiology. 2018; 129: 335-342
        • Sood G.
        • Argani C.
        • Ghanem K.G.
        • Perl T.M.
        • Sheffield J.S.
        Infections complicating cesarean delivery.
        Curr Opin Infect Dis. 2018; 31: 368-376
        • Bratzler D.W.
        • Dellinger E.P.
        • Olsen K.M.
        • et al.
        Clinical practice guidelines for antimicrobial prophylaxis in surgery.
        Am J Health Syst Pharm. 2013; 70: 195-283
      3. Prophylactic antibiotics in obstetrics and gynaecology. Melbourne, Australia. Royal Australian and New Zealand College of Obstetricians and Gynaecologists, 2016. Available at: https://www.ranzcog.edu.au/Statements-Guidelines. Accessed June 7, 2019.

        • ACOG Committee on Practice Bulletins
        Use of prophylactic antibiotics in labor and delivery. ACOG Practice Bulletin No. 199.
        Obstet Gynecol. 2018; 132: e103-e119
      4. Clinical guideline 132 Caesarean Section. United Kingdom: National Institute for Clinical and Healthcare Excellence, 2011. Available at: https://www.nice.org.uk/guidance/cg132. Accessed June 1, 2019.

        • Smaill F.M.
        • Grivell R.M.
        Antibiotic prophylaxis versus no prophylaxis for preventing infection after cesarean section.
        Cochrane Database Syst Rev. 2014; 10: CD007482
        • Andrews W.W.
        • Hauth J.C.
        • Cliver S.P.
        • Savage K.
        • Goldenberg R.L.
        Randomized clinical trial of extended spectrum antibiotic prophylaxis with coverage for Ureaplasma urealyticum to reduce post-cesarean delivery endometritis.
        Obstet Gynecol. 2003; 101: 1183-1189
      5. MIMS Online. Australia, 2019. Lincomycin. Available at: https://www.mimsonline.com.au. Accessed August 5, 2019.

      6. Medicines Complete. United Kingdom: British National Formulary, 2019. Obstetric and Gynaecological Surgery antibacterial prophylaxis. Available at: http://www.medicinescomplete.com. Accessed August 5, 2019.

        • Gyte G.M.
        • Dou L.
        • Vazquez J.C.
        Different classes of antibiotics given to women routinely for preventing infection at caesarean section.
        Cochrane Database Syst Rev. 2014; 11: CD008726
        • Kawakita J.T.
        • Huang J.C.-C.
        • Landy J.H.
        Choice of prophylactic antibiotics and surgical site infections after cesarean delivery.
        Obstet Gynecol. 2018; 132: 948-955
        • Hopkins M.K.
        • Dotters-Katz S.
        • Boggess K.
        • Heine R.P.
        • Smid M.
        Perioperative antibiotic choice in labored versus unlabored cesareans and risk of postcesarean infectious morbidity.
        Am J Perinatol. 2018; 35: 127-133
        • Tita A.T.
        • Szychowski J.M.
        • Boggess K.
        • et al.
        Adjunctive azithromycin prophylaxis for cesarean delivery.
        N Engl J Med. 2016; 375: 1231-1241
        • Ward E.
        • Duff P.
        A comparison of 3 antibiotic regimens for prevention of postcesarean endometritis: an historical cohort study.
        Am J Obstet Gynecol. 2016; 214: 751e1-751e4
        • Lamont R.F.
        • Sobel J.D.
        • Kusanovic J.P.
        • et al.
        Current debate on the use of antibiotic prophylaxis for caesarean section.
        BJOG. 2011; 118: 193-201
        • Mackeen A.D.
        • Packard R.E.
        • Ota E.
        • Berghella V.
        • Baxter J.K.
        Timing of intravenous prophylactic antibiotics for preventing postpartum infectious morbidity in women undergoing cesarean delivery.
        Cochrane Database Syst Rev. 2014; 12: CD009516
        • Costantine M.M.
        • Rahman M.
        • Ghulmiyah L.
        • et al.
        Timing of perioperative antibiotics for cesarean delivery: a metaanalysis.
        Am J Obstet Gynecol. 2008; 199: 301e1-301e6
        • Sullivan S.A.
        • Smith T.
        • Chang E.
        • Hulsey T.
        • Vandorsten J.P.
        • Soper D.
        Administration of cefazolin prior to skin incision is superior to cefazolin at cord clamping in preventing postcesarean infectious morbidity: a randomized, controlled trial.
        Am J Obstet Gynecol. 2007; 196: 455e1-455e5
        • Duffield A.
        • Sultan P.
        • Riley E.T.
        • Carvalho B.
        Optimal administration of cefazolin prophylaxis for cesarean delivery.
        J Perinatol. 2017; 37: 16-20
      7. eucast.org European Committee on Antimicrobial Susceptibility Testing. MIC and zone diameter distributions and ECOFFs. Available at: http://www.eucast.org/mic_distributions_and_ecoffs/. Accessed March 1, 2019.

        • Tipton A.M.
        • Cohen S.A.
        • Chelmow D.
        Wound infection in the obese pregnant woman.
        Semin Perinatol. 2011; 35: 345-349
        • Smid M.C.
        • Kearney M.S.
        • Stamilio D.M.
        Extreme obesity and postcesarean wound complications in the Maternal-Fetal Medicine Unit Cesarean Registry.
        Am J Perinatol. 2015; 32: 1336-1341
        • Valent A.M.
        • DeArmond C.
        • Houston J.M.
        • et al.
        Effect of post–cesarean delivery oral cephalexin and metronidazole on surgical site infection among obese women: a randomized clinical trial.
        JAMA. 2017; 318: 1026-1034
        • Grasch J.L.
        • Thompson J.L.
        • Newton J.M.
        • Zhai A.W.
        • Osmundson S.S.
        Trial of labor compared with cesarean delivery in superobese women.
        Obstet Gynecol. 2017; 130: 994-1000
        • Machado L.S.
        Cesarean section in morbidly obese parturients: practical implications and complications.
        N Am J Med Sci. 2012; 4: 13-18
        • Ma R.C.W.
        • Schmidt M.I.
        • Tam W.H.
        • McIntyre H.D.
        • Catalano P.M.
        Clinical management of pregnancy in the obese mother: before conception, during pregnancy, and postpartum.
        Lancet Diabetes Endocrinol. 2016; 4: 1037-1049
        • Brill M.J.
        • Houwink A.P.
        • Schmidt S.
        • et al.
        Reduced subcutaneous tissue distribution of cefazolin in morbidly obese versus non-obese patients determined using clinical microdialysis.
        J Antimicrob Chemother. 2013; 69: 715-723
        • Nightingale C.E.
        • Margarson M.P.
        • Shearer E.
        • et al.
        Peri-operative management of the obese surgical patient 2015: Association of Anaesthetists of Great Britain and Ireland Society for Obesity and Bariatric Anaesthesia.
        Anaesthesia. 2015; 70: 859-876
        • Kram J.J.F.
        • Greer D.M.
        • Cabrera O.
        • Burlage R.
        • Forgie M.M.
        • Siddiqui D.S.
        Does current cefazolin dosing achieve adequate tissue and blood concentrations in obese women undergoing cesarean section?.
        Eur J Obstet Gynecol Reprod Biol. 2017; 210: 334-341
        • Pevzner L.
        • Swank M.
        • Krepel C.
        • Wing D.A.
        • Chan K.
        • Edmiston C.E.
        Effects of maternal obesity on tissue concentrations of prophylactic cefazolin during cesarean delivery.
        Obstet Gynecol. 2011; 117: 877-882
        • Stitely M.
        • Sweet M.
        • Slain D.
        • et al.
        Plasma and tissue cefazolin concentrations in obese patients undergoing cesarean delivery and receiving differing pre-operative doses of drug.
        Surg Infect (Larchmt). 2013; 14: 455-459
        • Swank M.L.
        • Wing D.A.
        • Nicolau D.P.
        • McNulty J.A.
        Increased 3-gram cefazolin dosing for cesarean delivery prophylaxis in obese women.
        Am J Obstet Gynecol. 2015; 213: 451e1-451e8
        • Young O.M.
        • Shaik I.H.
        • Twedt R.
        • Binstock A.
        • Althouse A.D.
        • Venkataramanan R.
        • et al.
        . Pharmacokinetics of cefazolin prophylaxis in obese gravidae at time of cesarean delivery.
        Am J Obstet Gynecol. 2015; 213: 541e1-541e7
        • Maggio L.
        • Nicolau D.P.
        • DaCosta M.
        • Rouse D.J.
        • Hughes B.L.
        Cefazolin prophylaxis in obese women undergoing cesarean delivery: a randomized controlled trial.
        Obstet Gynecol. 2015; 125: 1205-1210
        • Grupper M.
        • Kuti J.L.
        • Swank M.L.
        • Maggio L.
        • Hughes B.L.
        • Nicolau D.P.
        Population pharmacokinetics of cefazolin in serum and adipose tissue from overweight and obese women undergoing Cesarean Delivery.
        J Clin Pharmacol. 2017; 57: 712-719
        • Marchand S.
        • Chauzy A.
        • Dahyot-Fizelier C.
        • Couet W.
        Microdialysis as a way to measure antibiotics concentration in tissues.
        Pharmacol Res. 2016; 111: 201-207
        • Pinto-Lopes R.
        • Sousa-Pinto B.
        • Azevedo L.F.
        Single dose versus multiple dose of antibiotic prophylaxis in caesarean section: a systematic review and meta-analysis.
        BJOG. 2017; 124: 595-605
        • Nabhan A.F.
        • Allam N.E.
        • Hamed Abdel-Aziz Salama M.
        Routes of administration of antibiotic prophylaxis for preventing infection after caesarean section.
        Cochrane Database Syst Rev. 2016; 6: CD011876
        • Rutayisire E.
        • Huang K.
        • Liu Y.
        • Tao F.
        The mode of delivery affects the diversity and colonization pattern of the gut microbiota during the first year of infants' life: a systematic review.
        BMC Gastroenterol. 2016; 16: 86
        • Stokholm J.
        • Thorsen J.
        • Chawes B.L.
        • et al.
        Cesarean section changes neonatal gut colonization.
        J Allergy Clin Immunol. 2016; 138: 881-889
        • Azad M.B.
        • Konya T.
        • Persaud R.R.
        • et al.
        Impact of maternal intrapartum antibiotics, method of birth and breastfeeding on gut microbiota during the first year of life: a prospective cohort study.
        BJOG. 2016; 23: 983-993
        • Schrag S.
        • Gorwitz R.
        • Fultz-Butts K.
        • Schuchat A.
        Prevention of perinatal group B streptococcal disease: revised guidelines from CDC.
        Morbidity Mortality Weekly Report. 2002; 11: 1-22
        • Kenyon S.
        • Boulvain M.
        • Neilson J.P.
        Antibiotics for preterm rupture of membranes.
        Cochrane Database Syst Rev. 2003; 2: CD001058
        • Ledger W.J.
        • Blaser M.J.
        Are we using too many antibiotics during pregnancy?.
        BJOG. 2013; 120: 1450-1452
        • Mueller N.T.
        • Whyatt R.
        • Hoepner L.
        • et al.
        Prenatal exposure to antibiotics, cesarean section and risk of childhood obesity.
        Int J Obes. 2014; 39: 665-670
        • Di Costanzo B.M.
        • Amoroso B.A.
        • Canani B.R.
        Gut microbiota as a target for food allergy.
        J Pediatr Gastroenterol Nutr. 2016; 63: S11-S13
        • Wopereis H.
        • Oozeer R.
        • Knipping K.
        • Belzer C.
        • Knol J.
        The first thousand days – intestinal microbiology of early life: establishing a symbiosis.
        Pediatr Allergy and Immunol. 2014; 25: 428-438
        • Jukka K.
        • Mika G.
        • Minna-Maija G.
        • et al.
        Mode of delivery and asthma – Is there a connection?.
        Pediatr Res. 2002; 52 (6–6)
        • Roduit C.
        • Scholtens S.
        • de Jongste J.C.
        • et al.
        Asthma at 8 years of age in children born by caesarean section.
        Thorax. 2009; 64: 107-113
        • Salas Garcia M.C.
        • Yee A.L.
        • Gilbert J.A.
        • Dsouza M.
        Dysbiosis in children born by caesarean section.
        Ann Nutr Metab. 2018; 73: 24-32
        • Padilha M.
        • Iaucci J.M.
        • Cabral V.P.
        • Diniz E.M.A.
        • Taddei C.R.
        • Saad S.M.I.
        Maternal antibiotic prophylaxis affects Bifidobacterium spp. counts in the human milk, during the first week after delivery.
        Benef Microbes. 2019; 10: 155-163
        • Keag O.E.
        • Norman J.E.
        • Stock S.J.
        Long-term risks and benefits associated with cesarean delivery for mother, baby, and subsequent pregnancies: Systematic review and meta-analysis.
        PLoS Med. 2018; 15e1002494
        • Montoya-Williams D.
        • Lemas D.J.
        • Spiryda L.
        • et al.
        The neonatal microbiome and its partial role in mediating the association between birth by cesarean section and adverse pediatric outcomes.
        Neonatology. 2018; 114: 103-111
        • Bailey S.R.
        • Field N.
        • Townsend C.L.
        • Rodger A.J.
        • Brocklehurst P.
        Antibiotic prophylaxis for women undergoing caesarean section and infant health.
        BJOG. 2016; 123: 875-876
        • Haas D.M.
        • Morgan S.
        • Contreras K.
        • Enders S.
        Vaginal preparation with antiseptic solution before cesarean section for preventing postoperative infections.
        Cochrane Database Syst Rev. 2018; 7: CD007892
        • Caissutti C.
        • Saccone G.
        • Zullo F.
        • et al.
        Vaginal cleansing before cesarean delivery: a systematic review and meta-analysis.
        Obstet Gynecol. 2017; 130: 527-538
        • La Rosa M.
        • Jauk V.
        • Saade G.
        • et al.
        Institutional protocols for vaginal preparation with antiseptic solution and surgical site infection rate in women undergoing cesarean delivery during labor.
        Obstet Gynecol. 2018; 132: 371-376
        • Martin E.K.
        • Beckmann M.M.
        • Barnsbee L.N.
        • Halton K.A.
        • Merollini K.
        • Graves N.
        Best practice perioperative strategies and surgical techniques for preventing caesarean section surgical site infections: a systematic review of reviews and meta-analyses.
        BJOG. 2018; 125: 956-964
        • Tuuli M.G.
        • Liu J.
        • Stout M.J.
        • et al.
        A randomized trial comparing skin antiseptic agents at cesarean delivery.
        N Engl J Med. 2016; 374: 647-655
        • Huang H.
        • Li G.
        • Wang H.
        • He M.
        Optimal skin antiseptic agents for prevention of surgical site infection in cesarean section: a meta-analysis with trial sequential analysis.
        J Matern Fetal Neonatal Med. 2018; 31: 3267-3274
        • Hadiati D.R.
        • Hakimi M.
        • Nurdiati D.S.
        • da Silva Lopes K.
        • Ota E.
        Skin preparation for preventing infection following caesarean section.
        Cochrane Database Syst Rev. 2018; 10: CD007462
        • Springel E.H.
        • Wang X.Y.
        • Sarfoh V.M.
        • Stetzer B.P.
        • Weight S.A.
        • Mercer B.M.
        A randomized open-label controlled trial of chlorhexidine-alcohol vs povidone-iodine for cesarean antisepsis: the CAPICA trial.
        Am J Obstet Gynecol. 2017; 217: 463e1-463e8
        • Ban K.A.
        • Minei J.P.
        • Laronga C.
        • et al.
        American College of Surgeons and Surgical Infection Society: surgical site infection guidelines, 2016 update.
        J Am Coll Surg. 2017; 224: 59-74
      8. Clinical guideline 125 Surgical site infections: prevention and treatment. United Kingdom: National Institute for Clinical and Healthcare Excellence, 2019. Available at: https://www.nice.org.uk/guidance/ng125. Accessed July 24, 2019.

        • Mahomed K.
        • Ibiebele I.
        • Buchanan J.
        The Betadine trial – antiseptic wound irrigation prior to skin closure at caesarean section to prevent surgical site infection: a randomised controlled trial.
        Aust NZ J Obstet Gynaecol. 2016; 56: 301-306
        • Eke A.C.
        • Shukr G.H.
        • Chaalan T.T.
        • Nashif S.K.
        • Eleje G.U.
        Intra-abdominal saline irrigation at cesarean section: a systematic review and meta-analysis.
        J Matern Fetal Neonatal Med. 2016; 29: 1588-1594
        • Stamilio D.M.
        • Scifres C.M.
        Extreme obesity and postcesarean maternal complications.
        Obstet Gynecol. 2014; 124: 227-232
        • Roberge S.
        • Demers S.
        • Berghella V.
        • Chaillet N.
        • Moore L.
        • Bujold E.
        Impact of single- vs double-layer closure on adverse outcomes and uterine scar defect: a systematic review and meta-analysis.
        Am J Obstet Gynecol. 2014; 211: 453-460
        • Zaki M.N.
        • Truong M.
        • Pyra M.
        • Kominiarek M.A.
        • Irwin T.
        Wound complications in obese women after cesarean: a comparison of staples versus subcuticular suture.
        J Perinatol. 2016; 36: 819-822
        • Gates S.
        • Anderson E.R.
        Wound drainage for caesarean section.
        Cochrane Database Syst Rev. 2013; 12: CD004549
        • Hellums E.K.
        • Lin M.G.
        • Ramsey P.S.
        Prophylactic subcutaneous drainage for prevention of wound complications after cesarean delivery–a meta-analysis.
        Am J Obstet Gynecol. 2007; 197: 229-235
        • American College of Obstetricians and Gynecologists
        Obesity in pregnancy. Practice Bulletin No. 156.
        Obstet Gynecol. 2015; 126: e112-e126
        • Looby M.A.
        • Vogel R.I.
        • Bangdiwala A.
        • Hyer B.
        • Das K.
        Prophylactic negative pressure wound therapy in obese patients following cesarean delivery.
        Surg Innov. 2018; 25: 43-49
        • Hyldig N.
        • Joergensen J.S.
        • Wu C.
        • et al.
        Cost-effectiveness of incisional negative pressure wound therapy compared with standard care after caesarean section in obese women: a trial-based economic evaluation.
        BJOG. 2019; 126: 619-627
        • Tuffaha H.W.
        • Gillespie B.M.
        • Chaboyer W.
        • Gordon L.G.
        • Scuffham P.A.
        Cost-utility analysis of negative pressure wound therapy in high-risk cesarean section wounds.
        J Surg Res. 2015; 195: 612-622
        • Smid M.C.
        • Dotters-Katz S.K.
        • Grace M.
        • et al.
        Prophylactic negative pressure wound therapy for obese women after cesarean delivery: a systematic review and meta-analysis.
        Obstet Gynecol. 2017; 130: 969-978
        • Hyldig N.
        • Vinter C.A.
        • Kruse M.
        • et al.
        Prophylactic incisional negative pressure wound therapy reduces the risk of surgical site infection after caesarean section in obese women: a pragmatic randomised clinical trial.
        BJOG. 2019; 26: 628-635